We are live on ! Find out more
TMO icon

Thermo Fisher Scientific
TMO

872 hedge funds and large institutions have $40.1B invested in Thermo Fisher Scientific in 2013 Q4 according to their latest regulatory filings, with 113 funds opening new positions, 253 increasing their positions, 381 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 113 | Existing positions closed: 53

27% more funds holding in top 10

Funds holding in top 10: 66 → 84 (+18)

22% more capital invested

Capital invested by funds: $32.8B → $40.1B (+$7.29B)

7% more funds holding

Funds holding: 817 → 872 (+55)

4% more call options, than puts

Call options by funds: $342M | Put options by funds: $328M

0.85% more ownership

Funds ownership: 98.8% → 99.65% (+0.85%)

34% less repeat investments, than reductions

Existing positions increased: 253 | Existing positions reduced: 381

Holders
872
Holders Change
+55
Holders Change %
+6.73%
% of All Funds
25.3%
Holding in Top 10
84
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+27.27%
% of All Funds
2.44%
New
113
Increased
253
Reduced
381
Closed
53
Calls
$342M
Puts
$328M
Net Calls
+$13.4M
Net Calls Change
+$117M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$148M
2
Citadel Advisors
Citadel Advisors
Florida
+$141M
3
CG
Carmignac Gestion
France
+$138M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$112M
5
O
OppenheimerFunds
New York
+$85.9M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$174M
2
TP
Third Point
New York
-$143M
3
PC
Paulson & Co
New York
-$101M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$91.5M
5
Charles Schwab
Charles Schwab
California
-$67.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
TP
876
Third Point
New York
– -$143M -1,550,000 Closed
SCM
877
SeaStone Capital Management
New York
– -$35M -379,595 Closed
MWNA
878
Marshall Wace North America
New York
– -$19.2M -208,206 Closed
MSU
879
Maple Securities USA
New Jersey
– -$7.98M -86,600 Closed
ARC
880
Absolute Return Capital
Massachusetts
– -$7.11M -77,109 Closed
MPM
881
Meritage Portfolio Management
Kansas
– -$7.08M -76,830 Closed
PWM
882
Patriot Wealth Management
Texas
– -$6.7M -72,670 Closed
ACPU
883
Arrowgrass Capital Partners (US)
Delaware
– -$4.61M -50,000 Closed
TA
884
Teton Advisors
New York
– -$4.52M -49,029 Closed
SCM
885
Sterling Capital Management
North Carolina
– -$4.23M -45,884 Closed
JGC
886
J. Goldman & Co
New York
– -$3.69M -40,000 Closed
SCM
887
Stevens Capital Management
Pennsylvania
– -$3.23M -35,009 Closed
BCM
888
Bridgeway Capital Management
Texas
– -$2.52M -27,300 Closed
Jane Street
889
Jane Street
New York
– -$2.48M -26,861 Closed
Arrowstreet Capital
890
Arrowstreet Capital
Massachusetts
– -$2.19M -23,731 Closed
GCC
891
Guardian Capital (Canada)
Ontario, Canada
– -$2.01M -21,860 Closed
MIU
892
Man Investments (UK)
United Kingdom
– -$1.53M -16,608 Closed
GCP
893
GSA Capital Partners
United Kingdom
– -$1.43M -15,502 Closed
MF
894
Magnetar Financial
Illinois
– -$1.28M -13,888 Closed
NBC
895
Neuberger Berman Canada
Ontario, Canada
– -$1.13M -12,300 Closed
JIM
896
Jupiter Investment Management
United Kingdom
– -$1.04M -11,300 Closed
GA
897
Geneva Advisors
Illinois
– -$929K -10,085 Closed
SH
898
Scepter Holdings
Texas
– -$875K -9,500 Closed
HCMT
899
Highland Capital Management (Texas)
Texas
– -$825K -8,949 Closed
DCM
900
Dynamic Capital Management
Jersey
– -$766K -8,313 Closed
34 35
36
37 38

TMO Hedge Fund Activity: Q4 2013 in Review

872 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2013, worth a combined $40.1B — up 22% from $32.8B a quarter earlier.

Buyers outnumbered sellers: 113 funds opened new TMO positions and 53 closed out — a net gain of 60 holders — while 253 added to existing stakes and 381 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $148M. The largest seller was PFM Health Sciences, cutting an estimated $174M.

  • 872 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2013, up from 817 in Q3 2013.
  • Funds reported $40.1B of Thermo Fisher Scientific stock for Q4 2013, up 22% quarter-over-quarter.
  • 113 funds opened new Thermo Fisher Scientific positions in Q4 2013 and 53 closed out, a net change of +60 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2013 was Fidelity Investments, an estimated $148M added.
  • The largest Thermo Fisher Scientific seller in Q4 2013 was PFM Health Sciences, an estimated $174M sold.

Based on aggregated 13F filings for Q4 2013.